The hydroxy-isostere of oxytocin has been shown to be three times more active than the hormone. However, it does not appear to offer any advantage over the hormone clinically because of a high pressor activity. Thus the pressor/oxytocic ratio (1/50) is three times greater than the corresponding ratio (1/150) for the hormone itself.
A particularly challenging problem in tumour biology is the endocrine effects of certain neoplasms. These effects have been well documented and are widely recognized. Less well recognized is the problem of distinguishing true ectopic endocrinopathies from similar syndromes caused by unrelated factors. Several of our patients illustrate this type of problem.
In a patient with oat cell carcinoma of the lung, the elevated plasma cortisol concentration, combined with low serum potassium and high serum bicarbonate suggested ectopic secretion of ACTH. This diagnosis was confirmed by demonstration of plasma ACTH concentrations of over 1000 pg/ml (normal <150) and by the ability of the tumour, on tissue culture, to continue to produce ACTH for more than four months after removal at autopsy. In this patient intravenous administration of potassium salts corrected the hypokalemic alkalosis but produced severe dilutional hyponatrwmia, with serum sodium of 1 15 mEq/litre and urea of 20 mg/100 ml.
In contrast, another patient with advanced bronchogenic carcinoma had hypokalemia, alkalosis, hyponatrwmia and a moderately elevated plasma cortisol concentration, which showed no diurnal variation. She had a diabetic glucose tolerance curve, and she excreted only 100 ml of a 1000 ml water load in five hours. In this patient, however, plasma ACTH was only 20 pg/ml, and the adrenals were not enlarged at autopsy. The hypokalkmic alkalosis had been caused by enthusiastic administration of diuretics, aud supplementary potassium had been given only with the diuretic, thus providing no protection. The hyponatremia and inability to excrete a water load were a result of advanced congestive heart failure, and the moderate elevation of plasma cortisol and the abnormal glucose tolerance test reflected the severe stress imposed Section ofEndocrinology on the patient by her advancing and life-threatening disease.
Another patient with acute myelocytic leukemia developed hypokalkmic alkalosis during an episode of granulocytopenia and infection. The initial impression that the leukemia was producing excessive ACTH seemed unlikely in view of the rarity with which this complication is seen in blood dyscrasias. More careful evaluation of the previous course suggested that the effect was due to large doses of gentamycin which inhibit renal tubular function. When the antibiotic was discontinued hypokalemia disappeared although, while the drug was being administered, even 100 mEq of potassium per day failed to correct the deficit.
The pattern of excessive secretion of vasopressin was mimicked in a patient with Hodgkin's disease, who had episodes of dilutional hyponatraemia, fever, convulsions and lymphopenia at approximately monthly intervals. After several such episodes, paralysis of the VI nerve also occurred. At this time, the suggestion that the tumour itself was producing vasopressin was revised, and it was considered more likely that the tumour had invaded the basal meninges, and was producing a variety of effects on the hypothalamus, including fever, leukopenia and water retention. Adequate treatment of the tumour resulted in disappearance of the episodes of hypothalamic dysfunction.
Many patients with disseminated cancer of the breast develop hypercalcxmia at some time during their course. Usually this is related to the presence of multiple osteolytic bone metastases, and is not associated with any particular abnormality in the plasma phosphate. In some patients, however, the elevated calcium level is accompanied by a depression of serum phosphate, a pattern reminiscent of hyperparathyroidism.
In one such patient impressive elevation of the plasma parathyroid hormone level was demonstrated by radioimmunoassay, and a biopsy of the tumour in an axillary lymph gland was found in vitro to dissolve bone in the same fashion as parathyroid hormone. In this patient, chemotherapy was followed by reduction in size of many of the tumour nodules and return of plasma calcium, phosphate and parathyroid hormone concentrations to normal. It seemed likely that the tumour was producing a substance with immunological and biological characteristics similar to parathyroid hormone.
In another patient with widely disseminated mammary cancer, the clinical picture of hyperparathyroidism was so accurately mimicked that preparations were under way to explore her neck. However, oophorectomy produced a prompt restoration of calcium and phosphate balance to normal. In this instance, such a manipulation with a highly specific effect on mammary tumours (removal of ovarian function) corrected the metabolic abnormalities and so strongly suggested that these mammary tumours were responsible for this pseudo-endocrine syndrome.
The interest of oncologists and endocrinologists in the ability of some tumours to release endocrine substances should not blind the physician to the possibility that other more mundane factors may be responsible for the observed metabolic derangements. 
